US Selumetinib Registry

TerminatedOBSERVATIONAL
Enrollment

37

Participants

Timeline

Start Date

January 4, 2019

Primary Completion Date

November 13, 2024

Study Completion Date

November 13, 2024

Conditions
Neurofibromatosis Type 1Plexiform Neurofibromas
Trial Locations (10)

10467

The Children's Hospital at Montefiore (CHAM), The Bronx

12208

Albany Medical Center, Albany

13210

Waters Center for Childrens Cancer and Blood Disorders, Syracuse

32806

Arnold Palmer Hospital For Children, Orlando

33155

Nicklaus Children's Hospital, Miami

55905

Mayo Clinic, Rochester

70121

Ochsner Medical Center, New Orleans

76104

Cook Children's Medical Center, Fort Worth

85016

Phoenix Children's Hospital, Phoenix

90027-6062

Children's Hospital Los Angeles, Los Angeles

Sponsors
All Listed Sponsors
lead

Alexion Pharmaceuticals, Inc.

INDUSTRY